NCT00295178View on ClinicalTrials.gov

Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 20, 2006

Primary Completion Date

August 9, 2006

Study Completion Date

August 9, 2006

Conditions
Cellulitis
Interventions
DRUG

Daptomycin

DRUG

Vancomycin

Trial Locations (1)

30909

Joseph Still Research Foundation, Augusta

All Listed Sponsors
lead

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT00295178 - Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas | Biotech Hunter | Biotech Hunter